Icosavax Stock Price, News & Analysis

ICVX NASDAQ

Company Description

Icosavax (NASDAQ: ICVX) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

ICVX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of ICVX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

50.1M

Shares outstanding

Icosavax (ICVX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

September 19, 2024

—

Frazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation Team

December 12, 2023

+49.48%

AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data

acquisition clinical trial

December 12, 2023

+49.48%

Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca

acquisition

December 12, 2023

+49.48%

Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults

clinical trial

November 14, 2023

+14.81%

Icosavax Reports Third Quarter 2023 Financial Results and Provides Corporate Update

earnings

November 8, 2023

+1.52%

Icosavax to Participate in the Jefferies London Healthcare Conference

conferences

Icosavax has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial, earnings, conferences. View all ICVX news →

SEC Filings

View All

No SEC filings available for ICVX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ICVX Company Profile & Sector Positioning

Icosavax (ICVX) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.